GB9828004D0 - Use - Google Patents

Use

Info

Publication number
GB9828004D0
GB9828004D0 GBGB9828004.3A GB9828004A GB9828004D0 GB 9828004 D0 GB9828004 D0 GB 9828004D0 GB 9828004 A GB9828004 A GB 9828004A GB 9828004 D0 GB9828004 D0 GB 9828004D0
Authority
GB
United Kingdom
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9828004.3A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Priority to GBGB9828004.3A priority Critical patent/GB9828004D0/en
Publication of GB9828004D0 publication Critical patent/GB9828004D0/en
Priority to AU24334/00A priority patent/AU2433400A/en
Priority to PCT/EP1999/010174 priority patent/WO2000037082A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
GBGB9828004.3A 1998-12-18 1998-12-18 Use Ceased GB9828004D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GBGB9828004.3A GB9828004D0 (en) 1998-12-18 1998-12-18 Use
AU24334/00A AU2433400A (en) 1998-12-18 1999-12-13 Use of 5-ht7 receptor antagonists for treating neuronal degeneration resulting from ischemic events
PCT/EP1999/010174 WO2000037082A1 (en) 1998-12-18 1999-12-13 Use of 5-ht7 receptor antagonists for treating neuronal degeneration resulting from ischemic events

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9828004.3A GB9828004D0 (en) 1998-12-18 1998-12-18 Use

Publications (1)

Publication Number Publication Date
GB9828004D0 true GB9828004D0 (en) 1999-02-10

Family

ID=10844566

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9828004.3A Ceased GB9828004D0 (en) 1998-12-18 1998-12-18 Use

Country Status (3)

Country Link
AU (1) AU2433400A (en)
GB (1) GB9828004D0 (en)
WO (1) WO2000037082A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4730096B2 (en) 2003-05-20 2011-07-20 味の素株式会社 Novel piperidine derivatives
AU2004283196B2 (en) 2003-09-17 2011-08-25 Janssen Pharmaceutica, N.V. Fused heterocyclic compounds
US7598255B2 (en) 2005-08-04 2009-10-06 Janssen Pharmaceutica Nv Pyrimidine compounds as serotonin receptor modulators
US20220023257A1 (en) * 2018-09-28 2022-01-27 Medizinische Hochschule Hannover (Mhh) Treatment of dementia-associated tauopathies

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000504677A (en) * 1996-02-09 2000-04-18 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー Sulfonamide derivatives for 5HT7 receptor antagonists
GB9612884D0 (en) * 1996-06-20 1996-08-21 Smithkline Beecham Plc Novel compounds
EP0912550A1 (en) * 1996-06-25 1999-05-06 Smithkline Beecham Plc Sulfonamide derivatives as 5ht7 receptor antagonists
JP4076234B2 (en) * 1996-06-28 2008-04-16 明治製菓株式会社 Tetrahydrobenzindole compounds
DE69829317T2 (en) * 1997-12-25 2006-04-06 Meiji Seika Kaisha Ltd. Tetrahydrobenzindole DERIVATIVES
JP2002515408A (en) * 1998-05-19 2002-05-28 アルコン ラボラトリーズ， インコーポレーテッド Serotonergic 5HT7 receptor compounds for the treatment of ocular and central nervous system disorders

Also Published As

Publication number Publication date
WO2000037082A1 (en) 2000-06-29
AU2433400A (en) 2000-07-12

Similar Documents

Publication Publication Date Title
DE69909613D1 (en) Bicyclische hydroxamsäurederivate
DE69924108D1 (en) Offshore-bohrsystem
DE59912932D1 (en) Arylphenylsubstituierte cyclische ketoenole
DE59912303D1 (en) Arylphenylsubstituierte cyclische ketoenole
DE69918845D1 (en) Polyketonlösung
DE69913545D1 (en) Pyrimidonderivate
PL343923A1 (en) New use
DE69943409D1 (en) Fmcw-radar
EA199900308A3 (en) Swichgear
DE69904335D1 (en) Aminomethylcarbonsäurederivate
DE69835235D1 (en) Thermoplastische silikonelastomere
DE69914921D1 (en) Phenyl-xanthinderivate
DE59903023D1 (en) Perorale wirkstoff-suspension
DE59914151D1 (en) Arylalkanoylpyridazine
GB9818914D0 (en) Use
DE69908871D1 (en) Thermisch härtbare glasplatte
DE69934603D1 (en) Elektrophotographischer photoconduktor
GB9814640D0 (en) New use
DE69915628D1 (en) Ritonavir-polymorph
DE60042897D1 (en) Photovervielfacherröhre
DE69938146D1 (en) Ptc-chip-thermistor
DE69939823D1 (en) Endo-beta-n-acetylglukosaminidase
DE69904442D1 (en) Cyclohexandiol-derivate
DE69905001D1 (en) Koagulationsvorrichtung
DE59904407D1 (en) Chromanderivate

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)